Boards
News
Market Data
Markets
Discover
Discover
AI Subscribe Login/Register account icon
S&P 500
7,022.95
(
0.80%
)
US TECH 100
25,535.20
(
1.56%
)
Dow Jones
48,463.72
(
-0.15%
)
Brent Oil
92.45
(
-0.23%
)
Bitcoin
74,851.25
(
0.03%
)
News Focus
News Focus
Post# of 405172
Next 10
Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next

Lemoncat

Send PM Follow Ignore
Followers 26
Posts 4067
Boards Moderated 0
Alias Born 12/26/2018

Lemoncat

Re: KMBJN post# 357280

Wednesday, 04/28/2021 11:38:29 AM

Wednesday, April 28, 2021 11:38:29 AM

Post# of 405172
You may yet get a 50% efficacy analysis. Enrollment just hit 50%. It will be another five weeks before all those patients are dosed and observed.

Hoping we'll stay on track and be done with enrollment in late June with protocol completion by August. Results in September or October.

Go IPIX!

Brilacidin! The hottest COVID-19 drug of 2023.

Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Last Read Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Detailed Quote